Mochida Pharmaceutical

4534.TPharmaceutical

Key numbers · FY ended 2026-03

Revenue¥117.0bn+11.2% YoY Operating income¥10.1bn+24.9% YoY Net income (owners)¥7.9bn+39.0% YoY Total assets¥182.7bn+14.1% YoY EPS (basic)¥222.96+39.0% YoY

Full financial history and reports →

Stock price4534 · View chart ↗

Open the price chart on TradingView.

Latest filings

Fri, Apr 10 · JST1 filing

10:585% STAKEMochida Pharmaceutical · Mochida Memorial Foundation for Medical and Pharmaceutical Research · 14.00% → 15.63%+1.63pp

All filings →

Major holders (5%+) · 1

Holder	Stake	Change	Filed
Mochida Memorial Foundation for Medical and Pharmaceutical Research	15.63%	—	2026-04-10

Each holder's own ratio from its most recent large-shareholding report.